These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 20595658)
1. Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial. Hankey GJ; Hacke W; Easton JD; Johnston SC; Mas JL; Brennan DM; Bhatt DL; Fox KA; Topol EJ; Stroke; 2010 Aug; 41(8):1679-83. PubMed ID: 20595658 [TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial). Dasgupta A; Steinhubl SR; Bhatt DL; Berger PB; Shao M; Mak KH; Fox KA; Montalescot G; Weber MA; Haffner SM; Dimas AP; Steg PG; Topol EJ; Am J Cardiol; 2009 May; 103(10):1359-63. PubMed ID: 19427428 [TBL] [Abstract][Full Text] [Related]
3. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. Bhatt DL; Flather MD; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Fabry-Ribaudo L; Hu T; Topol EJ; Fox KA; J Am Coll Cardiol; 2007 May; 49(19):1982-8. PubMed ID: 17498584 [TBL] [Abstract][Full Text] [Related]
4. Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial. Hankey GJ; Johnston SC; Easton JD; Hacke W; Mas JL; Brennan D; Mak KH; Bhatt DL; Fox KA; Topol EJ; Int J Stroke; 2011 Feb; 6(1):3-9. PubMed ID: 21205234 [TBL] [Abstract][Full Text] [Related]
5. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Kennedy J; Hill MD; Ryckborst KJ; Eliasziw M; Demchuk AM; Buchan AM; Lancet Neurol; 2007 Nov; 6(11):961-9. PubMed ID: 17931979 [TBL] [Abstract][Full Text] [Related]
6. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Wong KS; Chen C; Fu J; Chang HM; Suwanwela NC; Huang YN; Han Z; Tan KS; Ratanakorn D; Chollate P; Zhao Y; Koh A; Hao Q; Markus HS; Lancet Neurol; 2010 May; 9(5):489-97. PubMed ID: 20335070 [TBL] [Abstract][Full Text] [Related]
7. Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data. Diener HC; Bogousslavsky J; Brass LM; Cimminiello C; Csiba L; Kaste M; Leys D; Matias-Guiu J; Rupprecht HJ Cerebrovasc Dis; 2004; 17(2-3):253-61. PubMed ID: 14981346 [TBL] [Abstract][Full Text] [Related]
8. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Diener HC; Bogousslavsky J; Brass LM; Cimminiello C; Csiba L; Kaste M; Leys D; Matias-Guiu J; Rupprecht HJ; Lancet; 2004 Jul 24-30; 364(9431):331-7. PubMed ID: 15276392 [TBL] [Abstract][Full Text] [Related]
9. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Bhatt DL; Topol EJ; Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995 [TBL] [Abstract][Full Text] [Related]
10. Recent clinical trial results with antiplatelet therapy: implications in stroke prevention. Teal PA Cerebrovasc Dis; 2004; 17 Suppl 3():6-10. PubMed ID: 14730252 [TBL] [Abstract][Full Text] [Related]
11. Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial. Hart RG; Bhatt DL; Hacke W; Fox KA; Hankey GJ; Berger PB; Hu T; Topol EJ; Cerebrovasc Dis; 2008; 25(4):344-7. PubMed ID: 18303254 [TBL] [Abstract][Full Text] [Related]
12. Evolving perspectives on clopidogrel in the treatment of ischemic stroke. Gorelick P; Sechenova O; Hennekens CH J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):245-8. PubMed ID: 17220470 [TBL] [Abstract][Full Text] [Related]
13. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Berger PB; Bhatt DL; Fuster V; Steg PG; Fox KA; Shao M; Brennan DM; Hacke W; Montalescot G; Steinhubl SR; Topol EJ; Circulation; 2010 Jun; 121(23):2575-83. PubMed ID: 20516378 [TBL] [Abstract][Full Text] [Related]
14. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. Bhatt DL; Fox KA; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Flather MD; Haffner SM; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Brennan DM; Fabry-Ribaudo L; Booth J; Topol EJ; N Engl J Med; 2006 Apr; 354(16):1706-17. PubMed ID: 16531616 [TBL] [Abstract][Full Text] [Related]
16. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. ; Connolly SJ; Pogue J; Hart RG; Hohnloser SH; Pfeffer M; Chrolavicius S; Yusuf S N Engl J Med; 2009 May; 360(20):2066-78. PubMed ID: 19336502 [TBL] [Abstract][Full Text] [Related]
17. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Diener HC; Sacco RL; Yusuf S; Cotton D; Ounpuu S; Lawton WA; Palesch Y; Martin RH; Albers GW; Bath P; Bornstein N; Chan BP; Chen ST; Cunha L; Dahlöf B; De Keyser J; Donnan GA; Estol C; Gorelick P; Gu V; Hermansson K; Hilbrich L; Kaste M; Lu C; Machnig T; Pais P; Roberts R; Skvortsova V; Teal P; Toni D; VanderMaelen C; Voigt T; Weber M; Yoon BW; Lancet Neurol; 2008 Oct; 7(10):875-84. PubMed ID: 18757238 [TBL] [Abstract][Full Text] [Related]
18. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Bath PM; Cotton D; Martin RH; Palesch Y; Yusuf S; Sacco R; Diener HC; Estol C; Roberts R; Stroke; 2010 Apr; 41(4):732-8. PubMed ID: 20181679 [TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy in cerebrovascular disease: implications of Management of Artherothrombosis with Clopidogrel in High-risk Patients and the Clopidogrel for High Artherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance studies' results for cardiologists. Fintel DJ Clin Cardiol; 2007 Dec; 30(12):604-14. PubMed ID: 17847044 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial. Chen J; Bhatt DL; Dunn ES; Shi C; Caro JJ; Mahoney EM; Gabriel S; Jackson JD; Topol EJ; Cohen DJ Value Health; 2009 Sep; 12(6):872-9. PubMed ID: 19490556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]